Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues.

Tetsuya HosakaFumitaka SuzukiMasahiro KobayashiShunichirou FujiyamaYusuke KawamuraHitomi SezakiNorio AkutaYoshiyuki SuzukiSatoshi SaitohYasuji AraseKenji IkedaMariko KobayashiHiromitsu Kumada

Published in: Alimentary pharmacology & therapeutics (2019)

Patients with persistently high on-treatment HBcrAg levels were more likely to develop HCC despite sustained viral suppression via long-term NA treatment.

Keyphrases

sars cov
risk factors
molecular docking